Viewing Study NCT00920556


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-24 @ 7:33 PM
Study NCT ID: NCT00920556
Status: TERMINATED
Last Update Posted: 2019-02-27
First Post: 2009-06-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
Sponsor: Sirtris, a GSK Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 113222
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View